Suppr超能文献

高危肝细胞癌的手术切除:患者选择、术前考虑因素和手术技术。

Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique.

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Ann Surg Oncol. 2010 May;17(5):1219-25. doi: 10.1245/s10434-010-0976-5. Epub 2010 Apr 20.

Abstract

Hepatocellular carcinoma remains a leading cause of cancer death worldwide. There are an increasing number of patients that do not meet traditional criteria for surgical resection as a result of historically poor outcomes. We define these oncologically high-risk patients as those with either one of these risk factors or a combination of them: large (>5 cm) primary tumors, multinodular disease, and/or major vascular invasion. With appropriate selection and preparation, long-term survival is possible in this subset of patients after resection. This review focuses on the surgical treatment of these high-risk patients, focusing on our own institution's approach and methods as well as reviewing the literature pertinent to the support of our current practice.

摘要

肝细胞癌仍然是全球癌症死亡的主要原因。由于历史上预后较差,越来越多的患者不符合传统的手术切除标准。我们将这些具有以下任何一个或多个危险因素的肿瘤生物学高风险患者定义为:大(>5cm)原发性肿瘤、多结节性疾病和/或主要血管侵犯。经过适当的选择和准备,这部分患者在手术后可以获得长期生存。这篇综述重点讨论了这些高危患者的手术治疗,重点介绍了我们机构的方法和方法,并回顾了支持我们当前实践的相关文献。

相似文献

1
Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique.
Ann Surg Oncol. 2010 May;17(5):1219-25. doi: 10.1245/s10434-010-0976-5. Epub 2010 Apr 20.
2
Liver resection for HCC: patient's selection and controversial scenarios.
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):881-96. doi: 10.1016/j.bpg.2014.08.013. Epub 2014 Aug 23.
4
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
6
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
Oncologist. 2019 Aug;24(8):e730-e739. doi: 10.1634/theoncologist.2018-0898. Epub 2019 May 24.
7
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.
8
Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus: a new classification for surgical guidance.
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):263-9. doi: 10.1016/s1499-3872(13)60043-0.
9
Resection strategies for hepatocellular carcinoma.
Semin Liver Dis. 2013 Aug;33(3):273-81. doi: 10.1055/s-0033-1351782. Epub 2013 Aug 13.
10
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.
Liver Transpl. 2004 Feb;10(2 Suppl 1):S39-45. doi: 10.1002/lt.20040.

引用本文的文献

1
Neoadjuvant hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin for resectable single large hepatocellular carcinoma.
Int J Surg. 2025 Jun 1;111(6):3850-3858. doi: 10.1097/JS9.0000000000002437. Epub 2025 May 12.
3
Research progress of MRI-based radiomics in hepatocellular carcinoma.
Front Oncol. 2025 Feb 6;15:1420599. doi: 10.3389/fonc.2025.1420599. eCollection 2025.
4
Development of nomograms to predict outcomes for large hepatocellular carcinoma after liver resection.
Hepatol Int. 2025 Apr;19(2):428-440. doi: 10.1007/s12072-024-10754-7. Epub 2025 Jan 6.
6
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.
Cancer Res Commun. 2024 Aug 1;4(8):2123-2132. doi: 10.1158/2767-9764.CRC-24-0151.
7
Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study.
Clin Transl Radiat Oncol. 2024 Mar 27;46:100767. doi: 10.1016/j.ctro.2024.100767. eCollection 2024 May.
8
Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma.
Front Med (Lausanne). 2023 Nov 13;10:1325304. doi: 10.3389/fmed.2023.1325304. eCollection 2023.
9
Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.
Ann Surg Oncol. 2023 Dec;30(13):7935-7949. doi: 10.1245/s10434-023-14255-z. Epub 2023 Sep 11.

本文引用的文献

1
Efficacy of major hepatectomy for large hepatocellular carcinoma.
Hepatogastroenterology. 2009 May-Jun;56(91-92):768-72.
2
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.
Gastroenterology. 2009 Sep;137(3):850-5. doi: 10.1053/j.gastro.2009.06.003. Epub 2009 Jun 12.
4
Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?
J Formos Med Assoc. 2008 Aug;107(8):616-26. doi: 10.1016/S0929-6646(08)60179-5.
5
Sorafenib in advanced hepatocellular carcinoma.
N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.
6
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
Gastroenterology. 2008 Jun;134(7):1908-16. doi: 10.1053/j.gastro.2008.02.091. Epub 2008 Mar 8.
7
Comparison of two methods of future liver remnant volume measurement.
J Gastrointest Surg. 2008 Jan;12(1):123-8. doi: 10.1007/s11605-007-0323-8. Epub 2007 Oct 9.
8
Large hepatocellular carcinoma: time to stop preoperative biopsy.
J Am Coll Surg. 2007 Sep;205(3):453-62. doi: 10.1016/j.jamcollsurg.2007.04.033. Epub 2007 Jun 27.
9
Liver hanging maneuver for large or recurrent right upper quadrant tumors.
J Am Coll Surg. 2007 Feb;204(2):329-33. doi: 10.1016/j.jamcollsurg.2006.10.009. Epub 2006 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验